5B1zBcma

!,,
I
t I
I I
t_
I
I
6
I
? I
L
t
1
I
I
I
I
t
\
III
lHl:fl#fr il;rr#i'br#*:iiii*l;ri;gt[1.Jff:h':'fi
i,if i$'*'
Malta's life sciences industry is young but is
;;;;,;;r"w at a fast Pace' Havins afiract-
;"r;;; ;" *orld's leadi ng pharmacetttical
:;;;il;;;.stablish Plants on the island'
,t aou*ty is now aiming to move uP the
l,'iir"".i.iti*nposition " itilf as a global hub
;;;;il;t. nacked bY a multrmillk)n intlirn.ta
in infrastructure and lab facilities'
t"ii"lt ,"tt.,ing specialist drug developers
"ta ,t.*-"p biotech companies to establish
,nat"t"t""tih development units on the
"nd
i.'r""i- ttt" country's key atffaction centres
ot-ol""iai"g life sciences companies with
""t LJ" *"ira-class facilities but also direct
."ff"U"l,i"" with the island's universiry re-
Sewice' Malta's
t".*-tt.tt
""a ;;t';i;;.;t communitv "ational'Health promises procluctive
i"otrtio n."terships
that feed innovation'
scientiic advancement and support A NEW ROAD TO DISCOVERY
..,...,...,..
the commercialisation
of discoveries'
wiil. ,n" generics manufacruring industry
il'*'tt""to.'?;;te bedrock for Malta's research
"ii'i"u"rop*"nt capabilities' the industry
;;;,J'rh"t for ihe sector to srow and
oror'p", it n""aed to move further up the value
I""tI *rt"t. i tan carye out a niche as a locail;'i;;;;;;ist
drug develoPers and .startil;;ff
;;*Paniei' with'1" .'l*]]:1:
ii""i"r,tt" BioMalta campus' the country ls
ti"te term commitment to support
^j["g ;t,l;;fi develoPment
",,a of start-uPs and
,.i"'ri., tio,".tt flrms. It typically t"ry:.tb"::
ta
""att "ta costs up to 8oo million dollars to
;1i";;;;; ;'s ii"ou"ry to market' wth
llr o't in.t"asingly outsourcing develop-
;il;;;,i;"s "r*" and investing in Promising
ri""-*-*trt"t than performing studies and
arue aeu"topment of their own' Malta sees an
"pp?*ttty r" act as a feeder campus for Big
titt." and accelerate the growth of young
life science comPanies'
::}::::::::::T: ,
The qenerics pharmaceutical sector has been
;;;;;;" island's major success stories and
i"t many of the global leaders in
""t"""a initiallv came to the island
;il il;;,tv*ho
io1"t" tau.nt.ge of the country's legal frame-
*"*in.f .[-it the development of.generic
J*gt i" advance of patent expiry known
irTn" Exemption' Because of this legirf"tio",
"ot"t generic manufactures are able to
;"oiJil r"esearch and trials on drugs before
ii. p","", expires' Today companies such as
ii" e.t"uit cioup and Arrow Pharmaceutical'
Uottr owned by industry-giant Watson
ii.i*"..utl..ts, siegfried Holdings from
iwitzertanO, the Spanish Medichern Group'
emino Cnemicals of Italy and the Indian gen"ri.t
*"""f"cturer Aurobindo have significant
operations on the island'
PARK LIFE
anzelge
sir.,"gi..ffy positioned close to key stake-
"n"ri.it
i"'.n. industry' the state hospital
""U "ti"*tt,V, the BioMalta Campus is tarilji;;;;ietion
in zor4' rhe lo millionil;;i;
*h encomPass tn
.tt"i "f ,t:l:::
rqu"t" Ina*at and host research laboratortes
in' *"ai.in",
genetics and biotechnology'
ihe sioN{alta campus will also include an
incubation centre to support start-up companies
anO will encompass the whole inno-
Lii"" rlt" cycle and supply chain process
iJt-.o*n*t.t specialising in life sciences'
il";;; is'exPected to atffact foreign
iit..il"""t,*.nt to Malta and to sustain the
further development of Malta's home-grown
providing a new
iit" ,.i"tt."t communiry
;;;"";;; ;.t""rch institutes' technological
ii*t, "au."tional and medical training institutes
SUPPORTING GROWTH
Malta Enterprise is the government agency
ctraieeA with the task of establishing and manr*irg,it.
development of Malta's life sciences
iiau"stry, as well as overseeing the successfut
a.u"top*.nt of the BioMalta Campus' An
nneel tnvestor Network and a zoo million euro
invlstment fund are in the process of being set
uf in ota". to ttelp companies to bridge the gap
betteen conc"pt and commercialisation'
sCIENCE BASE
Malta is striving to follow in the footsteps or
countries such as Ireland, South Korea ano
Singapore, which have made huge galns ln
on.1*"..uti."1 manufacturing and R&D
ihanks to the implementation of governmentled
initiatives to boost the sector' By creaung
modern facilities for researchers and a supfortive
environment that offers assistance
in.lommerciatising ideas, Malta is hoping to
position itself as a meaningful player in the
world of life sciences' O